Marksans Pharma Ltd
NSE:MARKSANS
Marksans Pharma Ltd
NSE:MARKSANS
Price:
145.65 INR
-1.95%
Market Closed
Updated:
Jun 3, 2024
Marksans Pharma Ltd
Depreciation & Amortization
|
Marksans Pharma Ltd
Depreciation & Amortization Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Marksans Pharma Ltd
NSE:MARKSANS
|
Depreciation & Amortization
-₹671.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-17%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Depreciation & Amortization
-₹14.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Depreciation & Amortization
-₹10.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-11%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Depreciation & Amortization
-₹25.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-21%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Depreciation & Amortization
-₹7.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-14%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Depreciation & Amortization
-₹8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-25%
|
See Also
What is Marksans Pharma Ltd's Depreciation & Amortization?
Depreciation & Amortization
-671.6m
INR
-671.6m
INR
Based on the financial report for Dec 31, 2023, Marksans Pharma Ltd's Depreciation & Amortization amounts to -671.6m INR.
What is Marksans Pharma Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-17%
-17%
Over the last year, the Depreciation & Amortization growth was -13%. The average annual Depreciation & Amortization growth rates for Marksans Pharma Ltd have been -15% over the past three years , -24% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
